Skip to main content
Caspar Schatz on Muck Rack

Caspar Schatz

As seen in: Eureka!
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Caspar

Contact Caspar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Why tech transfer may be critical to beating COVID-19

|
By Paul Rutten, Caspar Schatz, Cormac O’Sullivan
| McKinsey & Company
Vaccines are considered to be our best chance for beating COVID-19, and many governments are counting on them to enable economic recovery. But to innoculate people worldwide as soon as vaccines are proven will require the pharmaceutical industry to ramp up quickly to unprecedented volumes of supply. The available global production capacity will be critical to that capability.
Open in Who Shared Issue with article?

Why tech transfer may be critical to beating COVID-19

|
By Cormac O’Sullivan, Paul Rutten, Caspar Schatz
| Eureka!
How quickly COVID-19 vaccine production ramps up will depend on technology transfer—the capabilities and processes that can speed vaccines from development to manufacturing. Are we ready? Vaccines are considered to be our best chance for beating COVID-19, and many governments are counting on them to enable economic recovery. But to innoculate people worldwide as soon as vaccines are proven will require the pharmaceutical industry to ramp up quickly to unprecedented volumes of supply.
Open in Who Shared Issue with article?
See all 2 articles